LHC Group Inc. (NASDAQ:LHCG) CEO Keith G. Myers sold 2,203 shares of the company’s stock in a transaction that occurred on Friday, November 18th. The shares were sold at an average price of $43.53, for a total value of $95,896.59. Following the completion of the sale, the chief executive officer now directly owns 144,615 shares in the company, valued at approximately $6,295,090.95. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of LHC Group Inc. (NASDAQ:LHCG) traded down 0.292% on Monday, hitting $43.373. The company had a trading volume of 70,593 shares. The company has a 50 day moving average of $37.96 and a 200-day moving average of $40.16. The company has a market cap of $788.35 million, a price-to-earnings ratio of 22.129 and a beta of 0.98. LHC Group Inc. has a 12-month low of $32.04 and a 12-month high of $48.10.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $0.54 EPS for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.04. LHC Group had a net margin of 3.84% and a return on equity of 9.59%. The business had revenue of $230 million for the quarter, compared to analyst estimates of $224.60 million. During the same quarter last year, the business earned $0.50 earnings per share. The business’s revenue for the quarter was up 13.1% on a year-over-year basis. On average, analysts forecast that LHC Group Inc. will post $2.07 earnings per share for the current year.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

A number of research analysts have weighed in on the company. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $49.00 price target on the stock in a research note on Tuesday, November 15th. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $46.00 price target (down previously from $50.00) on shares of LHC Group in a research note on Tuesday, September 13th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $48.00.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Cubist Systematic Strategies LLC raised its position in LHC Group by 12.0% in the second quarter. Cubist Systematic Strategies LLC now owns 2,357 shares of the company’s stock valued at $102,000 after buying an additional 253 shares during the period. Mason Street Advisors LLC acquired a new position in LHC Group during the second quarter valued at about $110,000. Emerald Acquisition Ltd. acquired a new position in LHC Group during the third quarter valued at about $114,000. BlackRock Inc. raised its position in LHC Group by 409.3% in the second quarter. BlackRock Inc. now owns 3,871 shares of the company’s stock valued at $167,000 after buying an additional 3,111 shares during the period. Finally, BNP Paribas Arbitrage SA raised its position in LHC Group by 110.9% in the second quarter. BNP Paribas Arbitrage SA now owns 4,340 shares of the company’s stock valued at $188,000 after buying an additional 2,282 shares during the period. Institutional investors and hedge funds own 81.42% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

5 Day Chart for NASDAQ:LHCG

Receive News & Stock Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related stocks with our FREE daily email newsletter.